impact factor
logo
 

One year in review

 

One year in review 2021: fibromyalgia


1, 2, 3, 4, 5, 6, 7, 8

 

  1. Department of Clinical Neurosciences, Hermanas Hospitalarias, Villa San Benedetto Menni Hospital, Como, and Humanitas Clinical and Research Centre, Milan, Italy.
  2. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Italy.
  3. Trauma and Orthopaedic Unit, Santissima Trinità Hospital, Cagliari, Italy.
  4. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Italy.
  5. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Italy.
  6. Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan, and University School of Medicine, Milan, Italy.
  7. Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan, and University School of Medicine, Milan, Italy.
  8. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Italy. atzenifabiola@hotmail.com

CER14641
2021 Vol.39, N°3 ,Suppl.130
PI 0003, PF 0012
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 34001307 [PubMed]

Received: 17/03/2021
Accepted : 02/04/2021
In Press: 13/05/2021
Published: 21/06/2021

Abstract

Fibromyalgia (FM) is a syndrome of unknown aetiology characterised by chronic pain, fatigue, and disturbed sleep. This review presents and summarises the 2020 literature on FM by retrieving all articles indexed in PubMed between 1 January 2020 and 31 December 2020. The attention of the scientific community towards FM is constantly growing, and this year’s review is focused on the diagnostic, pathogenetic and therapeutic aspects of this syndrome. In particular, the treatment options for FM, both pharmacological and non-pharmacological, have been extensively studied.

Rheumatology Article